Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,764
Closed -$1.16M 880
2023
Q2
$1.16M Buy
+6,764
New +$1.17M 0.06% 425
2023
Q1
Sell
-9,707
Closed -$1.42M 1817
2022
Q4
$1.42M Buy
9,707
+1,920
+25% +$284K 0.05% 362
2022
Q3
$1.16M Buy
7,787
+5,857
+303% +$979K 0.04% 432
2022
Q2
$332K Sell
1,930
-105,495
-98% -$18.2M 0.01% 1048
2022
Q1
$20.3M Buy
107,425
+94,677
+743% +$18.7M 0.77% 21
2021
Q4
$3.11M Buy
+12,748
New +$2.79M 0.12% 173
2021
Q3
Sell
-4,244
Closed -$791K 1746
2021
Q2
$791K Buy
+4,244
New +$737K 0.02% 593
2021
Q1
Sell
-40,980
Closed -$6.78M 1107
2020
Q4
$6.78M Buy
+40,980
New +$6.66M 0.22% 108

Other funds holding ZTS

Ergoteles's ZTS Position: Q3 2023 in Review

Ergoteles sold out of Zoetis (ZTS) in Q3 2023, closing a stake of 6,764 shares — an estimated $1.16M sold.

Ergoteles first reported a position in ZTS in Q4 2020 and held it in 8 quarters. The position peaked at $20.3M in Q1 2022. 1,628 funds tracked by Wall St. Rank hold ZTS as of Q3 2023.

  • Ergoteles reported no remaining Zoetis position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 6,764 Zoetis shares in Q3 2023, an estimated $1.16M.
  • Ergoteles first reported a position in Zoetis in Q4 2020 and held it in 8 quarters.
  • Ergoteles's Zoetis position peaked at $20.3M in Q1 2022.
  • 1,628 funds tracked by Wall St. Rank held Zoetis as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.